Mirae Asset Global Investments’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $106K | Buy |
6,603
+675
| +11% | +$10.8K | ﹤0.01% | 1129 |
|
2025
Q1 | $109K | Buy |
5,928
+1,037
| +21% | +$19.1K | ﹤0.01% | 1116 |
|
2024
Q4 | $120K | Sell |
4,891
-403
| -8% | -$9.87K | ﹤0.01% | 1121 |
|
2024
Q3 | $148K | Buy |
5,294
+934
| +21% | +$26.2K | ﹤0.01% | 1136 |
|
2024
Q2 | $113K | Sell |
4,360
-67,428
| -94% | -$1.75M | ﹤0.01% | 1127 |
|
2024
Q1 | $1.33M | Buy |
71,788
+35,589
| +98% | +$660K | ﹤0.01% | 1386 |
|
2023
Q4 | $1.53M | Sell |
36,199
-1,202
| -3% | -$50.6K | ﹤0.01% | 1392 |
|
2023
Q3 | $1.44M | Buy |
37,401
+1,059
| +3% | +$40.7K | ﹤0.01% | 1343 |
|
2023
Q2 | $686K | Sell |
36,342
-38,030
| -51% | -$717K | ﹤0.01% | 1798 |
|
2023
Q1 | $1.15M | Buy |
74,372
+51,593
| +226% | +$800K | ﹤0.01% | 1466 |
|
2022
Q4 | $404K | Buy |
22,779
+3,207
| +16% | +$56.9K | ﹤0.01% | 1998 |
|
2022
Q3 | $109K | Buy |
19,572
+5,040
| +35% | +$28.1K | ﹤0.01% | 2482 |
|
2022
Q2 | $57K | Buy |
+14,532
| New | +$57K | ﹤0.01% | 2376 |
|